{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T03:26:53Z","timestamp":1790652413108,"version":"4.1.0"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T00:00:00Z","timestamp":1782518400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T00:00:00Z","timestamp":1790121600000},"content-version":"vor","delay-in-days":88,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100014013","name":"UK Research and Innovation","doi-asserted-by":"publisher","award":["MC_PC_20060"],"award-info":[{"award-number":["MC_PC_20060"]}],"id":[{"id":"10.13039\/100014013","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Ethnic differences in SARS-CoV\u20112 vaccine immunogenicity have been reported after primary vaccination, but it remains unclear whether these disparities persist following booster doses or whether patterns of immune boosting and waning differ across ethnic groups. In this longitudinal study of healthcare workers enrolled in the BE\u2011DIRECT cohort, we evaluated humoral and cellular immune responses before booster vaccination, 3\u20134 weeks afterwards, and at approximately six months. Anti\u2011spike and neutralising antibodies, as well as T\u2011cell ELISpot responses to spike peptides, were quantified, and changes across boosting and waning phases were examined using multivariable regression adjusting for demographic factors, vaccine regimen, prior infection and baseline immune measures. South Asian participants demonstrated substantially higher post\u2011booster anti\u2011spike titres than White participants, although titres converged by six months. After adjustment, South Asian individuals exhibited greater increases in total anti-spike and neutralising antibody titres, while decline in antibody titres between post-booster and six-month post-booster sampling points were similar across ethnic groups. T\u2011cell responses during the boosting phase did not differ, but decline of S2\u2011specific and overall spike\u2011specific T\u2011cell responses between post-booster and six-month post-booster sampling points occurred more slowly in South Asians. These findings indicate that South Asian healthcare workers mount stronger early booster\u2011induced antibody responses and exhibit more sustained T\u2011cell immunity, highlighting the need to understand underlying mechanisms and implications for vaccine effectiveness.<\/jats:p>","DOI":"10.1038\/s41598-026-54217-5","type":"journal-article","created":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T05:34:41Z","timestamp":1782538481000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["The impact of ethnicity on longitudinal humoral and cellular immune responses to SARS-CoV-2 booster vaccination"],"prefix":"10.1038","volume":"16","author":[{"given":"Christopher A.","family":"Martin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua","family":"Nazareth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucy","family":"Teece","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sam","family":"Scott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amar","family":"Jarkhi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mrinal","family":"Das","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luke","family":"Bryant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nisha","family":"George","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marjan","family":"Gohar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valerie","family":"Renals","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victoria","family":"Wenn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Denny","family":"Vail","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aleesha","family":"Karia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Moss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian J.","family":"Willett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Tattersall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bassam","family":"Hallis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashley D.","family":"Otter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cathy","family":"Rowe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pranab","family":"Haldar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Cooper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manish","family":"Pareek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,27]]},"reference":[{"key":"54217_CR1","doi-asserted-by":"publisher","unstructured":"Irizar, P. et al. Ethnic inequalities in COVID-19 infection, hospitalisation, intensive care admission, and death: a global systematic review and meta-analysis of over 200 million study participants. eClinicalMedicine 57 https:\/\/doi.org\/10.1016\/j.eclinm.2023.101877 (2023).","DOI":"10.1016\/j.eclinm.2023.101877"},{"issue":"9","key":"54217_CR2","doi-asserted-by":"publisher","first-page":"e475","DOI":"10.1016\/S2468-2667(20)30164-X","volume":"5","author":"LH Nguyen","year":"2020","unstructured":"Nguyen, L. H. et al. Risk of COVID-19 among front-line health-care workers and the general community: a prospective cohort study. Lancet Public. Health. 5 (9), e475\u2013e83. https:\/\/doi.org\/10.1016\/S2468-2667(20)30164-X (2020).","journal-title":"Lancet Public. Health"},{"key":"54217_CR3","doi-asserted-by":"publisher","first-page":"m3582","DOI":"10.1136\/bmj.m3582","volume":"371","author":"ASV Shah","year":"2020","unstructured":"Shah, A. S. V. et al. Risk of hospital admission with coronavirus disease 2019 in healthcare workers and their households: nationwide linkage cohort study. BMJ 371, m3582. https:\/\/doi.org\/10.1136\/bmj.m3582 (2020).","journal-title":"BMJ"},{"issue":"12","key":"54217_CR4","doi-asserted-by":"publisher","first-page":"1439","DOI":"10.1016\/S2213-2600(21)00380-5","volume":"9","author":"U Agrawal","year":"2021","unstructured":"Agrawal, U. et al. COVID-19 hospital admissions and deaths after BNT162b2 and ChAdOx1 nCoV-19 vaccinations in 2.57 million people in Scotland (EAVE II): a prospective cohort study. Lancet Respiratory Med. 9 (12), 1439\u20131449. https:\/\/doi.org\/10.1016\/S2213-2600(21)00380-5 (2021).","journal-title":"Lancet Respiratory Med."},{"issue":"8","key":"54217_CR5","doi-asserted-by":"publisher","first-page":"1370","DOI":"10.1038\/s41591-021-01410-w","volume":"27","author":"E Pritchard","year":"2021","unstructured":"Pritchard, E. et al. Impact of vaccination on new SARS-CoV-2 infections in the United Kingdom. Nat. Med. 27 (8), 1370\u20131378. https:\/\/doi.org\/10.1038\/s41591-021-01410-w (2021).","journal-title":"Nat. Med."},{"key":"54217_CR6","unstructured":"Joint Committee on Vaccination and Immunisation. Joint Committee on Vaccination and Immunisation: advice on priority groups for COVID-19 vaccination, 30 December 2020 2021 [cited 2022 25th April]. (2020). Available from: https:\/\/www.gov.uk\/government\/publications\/priority-groups-for-coronavirus-covid-19-vaccination-advice-from-the-jcvi-30-december-2020\/joint-committee-on-vaccination-and-immunisation-advice-on-priority-groups-for-covid-19-vaccination-30-december."},{"issue":"5","key":"54217_CR7","doi-asserted-by":"publisher","first-page":"e2310650","DOI":"10.1001\/jamanetworkopen.2023.10650","volume":"6","author":"F Menegale","year":"2023","unstructured":"Menegale, F. et al. Evaluation of Waning of SARS-CoV-2 Vaccine\u2013Induced Immunity: A Systematic Review and Meta-analysis. JAMA Netw. Open. 6 (5), e2310650\u2013e. https:\/\/doi.org\/10.1001\/jamanetworkopen.2023.10650 (2023).","journal-title":"JAMA Netw. Open."},{"key":"54217_CR8","doi-asserted-by":"publisher","first-page":"o1277","DOI":"10.1136\/bmj.o1277","volume":"377","author":"J Wise","year":"2022","unstructured":"Wise, J. Covid-19: JCVI advises further booster for vulnerable adults and health and care workers. BMJ 377, o1277. https:\/\/doi.org\/10.1136\/bmj.o1277 (2022).","journal-title":"BMJ"},{"key":"54217_CR9","doi-asserted-by":"publisher","unstructured":"Pan, D. et al. Are clinical outcomes from COVID-19 improving in ethnic minority groups? eClinicalMedicine. 61. https:\/\/doi.org\/10.1016\/j.eclinm.2023.102091 (2023).","DOI":"10.1016\/j.eclinm.2023.102091"},{"key":"54217_CR10","doi-asserted-by":"publisher","unstructured":"Martin, C. A. et al. Ethnic differences in cellular and humoral immune responses to SARS-CoV-2 vaccination in UK healthcare workers: a cross-sectional analysis. eClinicalMedicine 58 https:\/\/doi.org\/10.1016\/j.eclinm.2023.101926 (2023).","DOI":"10.1016\/j.eclinm.2023.101926"},{"key":"54217_CR11","doi-asserted-by":"publisher","unstructured":"Otter, A. D. et al. Determinants of SARS-CoV-2 anti-spike antibody levels following BNT162b2 vaccination: cross-sectional analysis of 6,000 SIREN study participants. medRxiv. 2022:2022.04.21.22274025. https:\/\/doi.org\/10.1101\/2022.04.21.22274025.","DOI":"10.1101\/2022.04.21.22274025"},{"key":"54217_CR12","doi-asserted-by":"crossref","unstructured":"Jolliffe, D. A. et al. Determinants of antibody responses to SARS-CoV-2 vaccines: Population-based longitudinal study (COVIDENCE UK). Vaccines [Internet] 10(10). (2022).","DOI":"10.3390\/vaccines10101601"},{"issue":"10","key":"54217_CR13","doi-asserted-by":"publisher","first-page":"970","DOI":"10.1136\/jech-2020-216061","volume":"75","author":"SV Katikireddi","year":"2021","unstructured":"Katikireddi, S. V. et al. Unequal impact of the COVID-19 crisis on minority ethnic groups: a framework for understanding and addressing inequalities. J. Epidemiol. Community Health. 75 (10), 970. https:\/\/doi.org\/10.1136\/jech-2020-216061 (2021).","journal-title":"J. Epidemiol. Community Health"},{"key":"54217_CR14","doi-asserted-by":"publisher","first-page":"1139915","DOI":"10.3389\/fimmu.2023.1139915","volume":"14","author":"MM Jenkins","year":"2023","unstructured":"Jenkins, M. M. et al. Longitudinal analysis of SARS-CoV-2 infection and vaccination in the LA-SPARTA cohort reveals increased risk of infection in vaccinated Hispanic participants. Front. Immunol. 14, 1139915 (2023). PubMed PMID: 37153624.","journal-title":"Front. Immunol."},{"key":"54217_CR15","doi-asserted-by":"crossref","unstructured":"Mack, P. C. et al. Time-dependent effects of clinical interventions on SARS-CoV-2 immunity in patients with lung cancer. Vaccines [Internet] 12(7). (2024).","DOI":"10.3390\/vaccines12070713"},{"issue":"7","key":"54217_CR16","doi-asserted-by":"publisher","first-page":"1760","DOI":"10.1038\/s41591-023-02414-4","volume":"29","author":"E Barnes","year":"2023","unstructured":"Barnes, E. et al. SARS-CoV-2-specific immune responses and clinical outcomes after COVID-19 vaccination in patients with immune-suppressive disease. Nat. Med. 29 (7), 1760\u20131774. https:\/\/doi.org\/10.1038\/s41591-023-02414-4 (2023).","journal-title":"Nat. Med."},{"issue":"54","key":"54217_CR17","doi-asserted-by":"publisher","first-page":"eabf3698","DOI":"10.1126\/sciimmunol.abf3698","volume":"5","author":"CJ Reynolds","year":"2020","unstructured":"Reynolds, C. J. et al. Discordant neutralizing antibody and T cell responses in asymptomatic and mild SARS-CoV-2 infection. Sci. Immunol. 5 (54), eabf3698. https:\/\/doi.org\/10.1126\/sciimmunol.abf3698 (2020).","journal-title":"Sci. Immunol."},{"issue":"2","key":"54217_CR18","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1038\/s41590-021-01122-w","volume":"23","author":"P Moss","year":"2022","unstructured":"Moss, P. The T cell immune response against SARS-CoV-2. Nat. Immunol. 23 (2), 186\u2013193. https:\/\/doi.org\/10.1038\/s41590-021-01122-w (2022).","journal-title":"Nat. Immunol."},{"issue":"1","key":"54217_CR19","doi-asserted-by":"publisher","first-page":"5061","DOI":"10.1038\/s41467-021-25167-5","volume":"12","author":"DT Skelly","year":"2021","unstructured":"Skelly, D. T. et al. Two doses of SARS-CoV-2 vaccination induce robust immune responses to emerging SARS-CoV-2 variants of concern. Nat. Commun. 12 (1), 5061 (2021). PubMed PMID: 34404775.","journal-title":"Nat. Commun."},{"key":"54217_CR20","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.puhe.2022.04.009","volume":"208","author":"N Salari","year":"2022","unstructured":"Salari, N. et al. Efficacy of COVID-19 vaccines by race and ethnicity. Public. Health. 208, 14\u201317 (2022). PubMed PMID: 35660280.","journal-title":"Public. Health"},{"issue":"6","key":"54217_CR21","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1136\/jech.2003.013466","volume":"58","author":"R Bhopal","year":"2004","unstructured":"Bhopal, R. Glossary of terms relating to ethnicity and race: for reflection and debate. J. Epidemiol. Community Health. 58 (6), 441. https:\/\/doi.org\/10.1136\/jech.2003.013466 (2004).","journal-title":"J. Epidemiol. Community Health"},{"issue":"1","key":"54217_CR22","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1038\/s41591-022-02078-6","volume":"29","author":"AJ Mentzer","year":"2023","unstructured":"Mentzer, A. J. et al. Human leukocyte antigen alleles associate with COVID-19 vaccine immunogenicity and risk of breakthrough infection. Nat. Med. 29 (1), 147\u2013157. https:\/\/doi.org\/10.1038\/s41591-022-02078-6 (2023).","journal-title":"Nat. Med."},{"key":"54217_CR23","doi-asserted-by":"publisher","first-page":"20842","DOI":"10.1038\/srep20842","volume":"6","author":"Y Avnir","year":"2016","unstructured":"Avnir, Y. et al. IGHV1-69 polymorphism modulates anti-influenza antibody repertoires, correlates with IGHV utilization shifts and varies by ethnicity. Sci. Rep. 6, 20842 (2016). PubMed PMID: 26880249.","journal-title":"Sci. Rep."},{"issue":"6","key":"54217_CR24","doi-asserted-by":"publisher","first-page":"1106","DOI":"10.1136\/gutjnl-2021-326563","volume":"71","author":"CN Siew","year":"2022","unstructured":"Siew, C. N. et al. Gut microbiota composition is associated with SARS-CoV-2 vaccine immunogenicity and adverse events. Gut 71 (6), 1106. https:\/\/doi.org\/10.1136\/gutjnl-2021-326563 (2022).","journal-title":"Gut"},{"issue":"12","key":"54217_CR25","doi-asserted-by":"publisher","first-page":"e2006842","DOI":"10.1371\/journal.pbio.2006842","volume":"16","author":"AW Brooks","year":"2018","unstructured":"Brooks, A. W., Priya, S., Blekhman, R. & Bordenstein, S. R. Gut microbiota diversity across ethnicities in the United States. PLoS Biol. 16 (12), e2006842 (2018). PubMed PMID: 30513082.","journal-title":"PLoS Biol."},{"issue":"6","key":"54217_CR26","doi-asserted-by":"publisher","first-page":"e172","DOI":"10.1016\/j.jinf.2022.10.011","volume":"85","author":"J Nazareth","year":"2022","unstructured":"Nazareth, J. et al. Intra-season waning of immunity following the seasonal influenza vaccine in early and late vaccine recipients. J. Infect. 85 (6), e172\u2013e4. https:\/\/doi.org\/10.1016\/j.jinf.2022.10.011 (2022).","journal-title":"J. Infect."},{"key":"54217_CR27","unstructured":"Office for National Statistics. Ethnic group, national identity and religion [cited 2021 7th July]. Available from: https:\/\/www.ons.gov.uk\/methodology\/classificationsandstandards\/measuringequality\/ethnicgroupnationalidentityandreligion."},{"issue":"8","key":"54217_CR28","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.1038\/s41564-022-01143-7","volume":"7","author":"BJ Willett","year":"2022","unstructured":"Willett, B. J. et al. SARS-CoV-2 Omicron is an immune escape variant with an altered cell entry pathway. Nat. Microbiol. 7 (8), 1161\u20131179. https:\/\/doi.org\/10.1038\/s41564-022-01143-7 (2022).","journal-title":"Nat. Microbiol."},{"issue":"1","key":"54217_CR29","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1038\/s41590-021-01089-8","volume":"23","author":"AC Dowell","year":"2022","unstructured":"Dowell, A. C. et al. Children develop robust and sustained cross-reactive spike-specific immune responses to SARS-CoV-2 infection. Nat. Immunol. 23 (1), 40\u201349. https:\/\/doi.org\/10.1038\/s41590-021-01089-8 (2022).","journal-title":"Nat. Immunol."},{"issue":"6","key":"54217_CR30","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1093\/infdis\/jiaa788","volume":"223","author":"EC Hughes","year":"2021","unstructured":"Hughes, E. C. et al. Severe Acute Respiratory Syndrome Coronavirus 2 Serosurveillance in a Patient Population Reveals Differences in Virus Exposure and Antibody-Mediated Immunity According to Host Demography and Healthcare Setting. J. Infect. Dis. 223 (6), 971\u2013980 (2021). PubMed PMID: 33367847.","journal-title":"J. Infect. Dis."},{"key":"54217_CR31","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.trsl.2021.10.004","volume":"240","author":"C Doba\u00f1o","year":"2022","unstructured":"Doba\u00f1o, C. et al. Spike-based COVID-19 immunization increases antibodies to nucleocapsid antigen. Translational Res. 240, 26\u201332. https:\/\/doi.org\/10.1016\/j.trsl.2021.10.004 (2022).","journal-title":"Translational Res."},{"key":"54217_CR32","doi-asserted-by":"publisher","DOI":"10.1016\/j.lanepe.2024.101022","author":"J Nazareth","year":"2024","unstructured":"Nazareth, J. et al. Immunogenicity of concomitant SARS-CoV-2 and influenza vaccination in UK healthcare workers: a prospective longitudinal observational study. Lancet Reg. Health \u2013 Europe. https:\/\/doi.org\/10.1016\/j.lanepe.2024.101022 (2024).","journal-title":"Lancet Reg. Health \u2013 Europe"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-54217-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-54217-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-54217-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T04:02:21Z","timestamp":1790395341000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-54217-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,27]]},"references-count":32,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["54217"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-54217-5","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,27]]},"assertion":[{"value":"23 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"PM has received honoraria from Moderna, AstraZeneca and GSK, support for attending meetings from AstraZeneca and has participated on an advisory board for AstraZeneca. PH received an honorarium for hosting a COVID-19 webinar, on behalf of Oxford Immunotec (now Revvity) who are manufacturers of the ELISpot technology used in the manuscript. MP reports grants from UKRI-MRC for the current work and UKRI-MRC, NIHR, Sanofi and Gilead outside the current work and has received consulting fees from QIAGEN.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"BE-DIRECT was approved by the Health Research Authority (Brighton and Sussex Research Ethics Committee; ethics reference: 20\/HRA\/4718). Participants gave written consent prior to any study procedures. All research was performed in accordance with relevant guidelines\/regulations.","order":2,"name":"Ethics","label":"Ethical approval","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"29559"}}